Need Help? +1‪(801) 896-7142‬

Coupons

25% for bulk orders worth $7000+ – FRESHRX25%

Free shipping On qualified orders! – RXFREESHIP

20% off bulk orders! – FRESHRX20%

5% off all new orders! – FRESHRX5%

30% of mega bulk orders – FRESHRX30%

15% off all BTC orders – 15%OFFBTC

Product Detail

Sale!

400mcg Actiq (Fentanyl lollipop)

Original price was: $210.90.Current price is: $155.75.

Actiq (Fentanyl lollipop) is a potent opioid analgesic used to manage breakthrough cancer pain in opioid-tolerant patients. It should be used cautiously due to the risk of misuse, addiction, and overdose. Patients must be closely monitored for signs of respiratory depression and other adverse effects. This medication is specifically designed for individuals requiring continuous pain relief when other pain management options are insufficient. It works by binding to opioid receptors in the brain, reducing the perception of pain. Actiq is available as a lozenge on a handle (lollipop) for oral transmucosal administration. Each unit contains 400mcg of Fentanyl and should be used exactly as prescribed, with the handle placed in the mouth and allowed to dissolve slowly without chewing or sucking. Actiq is manufactured by Teva Pharmaceuticals and should be stored at room temperature, protected from light, and out of reach of children and pets.

Description

What is Actiq (Fentanyl lollipop)?

Actiq (Fentanyl lollipop) is a potent medication doctors use to manage severe pain in opioid-tolerant patients.It belongs to opioid analgesics, which bind to brain opioid receptors, reducing pain perception.Actiq is for patients needing continuous pain relief when other methods are inadequate.

Active Ingredients:

Each Actiq unit contains 400mcg of Fentanyl, a potent opioid analgesic known for its effectiveness in relieving pain. However, caution is necessary due to its potential for misuse, addiction, and overdose.

Indications:

Actiq manages breakthrough cancer pain in patients already receiving and tolerant to around-the-clock opioid therapy. Breakthrough pain is sudden and severe despite long-acting opioids.

Dosage:
Doctors should individualize Actiq dosage based on the patient’s response to treatment, pain intensity, and previous opioid use. They typically start opioid-tolerant patients at 200mcg, adjusting based on response. Doctors should use Actiq cautiously in elderly or debilitated patients, who may be more sensitive to opioids.

Contraindications:
Do not use Actiq in patients who are not opioid-tolerant, as it may cause respiratory depression and death. Avoid in patients with significant respiratory depression, acute or severe bronchial asthma, or hypercarbia.

Side EffectsActiq may cause nausea, vomiting, constipation, dizziness, and drowsiness. It may also lead to respiratory depression, sedation, and addiction. Patients need close monitoring for respiratory depression signs, especially when starting or increasing the dosage.

Precautions:

Use Actiq with caution in patients with a history of substance abuse, as they may be at increased risk of misuse, addiction, and overdose. Additionally, exercise caution in patients with a history of head injury, brain tumor, or increased intracranial pressure, as opioids may obscure the clinical course of these conditions.

Storage Instructions:
Actiq should be stored at room temperature (25°C/77°F) and protected from light. It should be kept out of reach of children and pets.

Manufacture Information:
Teva Pharmaceuticals manufactures Actiq, available as a lozenge on a handle (lollipop) for oral transmucosal administration.

Warnings:

Healthcare professionals knowledgeable in potent opioid use for chronic pain should prescribe Actiq, containing fentanyl, prone to abuse and overdose.

Direction of Use:Use Actiq by placing the lozenge in your mouth and allowing it to dissolve slowly. Do not suck or chew the handle. Use Actiq as prescribed and do not share it.

Conclusion:
In conclusion, healthcare providers use Actiq (Fentanyl lollipop) as a potent opioid analgesic to manage breakthrough cancer pain in opioid-tolerant patients. Due to its potential for misuse, addiction, and overdose, caution is necessary. Patients require close monitoring for signs of respiratory depression and other adverse effects.

RELATED PRODUCTS